126 related articles for article (PubMed ID: 31309127)
1. RNA Virus-Based Episomal Vector with a Fail-Safe Switch Facilitating Efficient Genetic Modification and Differentiation of iPSCs.
Komatsu Y; Takeuchi D; Tokunaga T; Sakurai H; Makino A; Honda T; Ikeda Y; Tomonaga K
Mol Ther Methods Clin Dev; 2019 Sep; 14():47-55. PubMed ID: 31309127
[TBL] [Abstract][Full Text] [Related]
2. Development of an RNA Virus-Based Episomal Vector Capable of Switching Transgene Expression.
Yamamoto Y; Tomonaga K; Honda T
Front Microbiol; 2019; 10():2485. PubMed ID: 31781052
[TBL] [Abstract][Full Text] [Related]
3. The Borna Disease Virus 2 (BoDV-2) Nucleoprotein Is a Conspecific Protein That Enhances BoDV-1 RNA-Dependent RNA Polymerase Activity.
Kanda T; Horie M; Komatsu Y; Tomonaga K
J Virol; 2021 Oct; 95(21):e0093621. PubMed ID: 34406860
[TBL] [Abstract][Full Text] [Related]
4. Stability of Borna disease virus-based episomal vector under physical and chemical stimulation.
Yanai M; Sakai M; Komorizono R; Makino A; Tomonaga K
Microbiol Immunol; 2022 Jan; 66(1):24-30. PubMed ID: 34617609
[TBL] [Abstract][Full Text] [Related]
5. Optimal Expression of the Envelope Glycoprotein of Orthobornaviruses Determines the Production of Mature Virus Particles.
Sakai M; Fujita Y; Komorizono R; Kanda T; Komatsu Y; Noda T; Tomonaga K; Makino A
J Virol; 2021 Mar; 95(5):. PubMed ID: 33268525
[TBL] [Abstract][Full Text] [Related]
6. In vivo biodistribution analysis of transmission competent and defective RNA virus-based episomal vector.
Komatsu Y; Tanaka C; Komorizono R; Tomonaga K
Sci Rep; 2020 Apr; 10(1):5890. PubMed ID: 32246020
[TBL] [Abstract][Full Text] [Related]
7. Optimization of episomal reprogramming for generation of human induced pluripotent stem cells from fibroblasts.
Bang JS; Choi NY; Lee M; Ko K; Lee HJ; Park YS; Jeong D; Chung HM; Ko K
Anim Cells Syst (Seoul); 2018; 22(2):132-139. PubMed ID: 30460090
[TBL] [Abstract][Full Text] [Related]
8. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
[TBL] [Abstract][Full Text] [Related]
9. Establishment of integration-free induced pluripotent stem cells from human recessive dystrophic epidermolysis bullosa keratinocytes.
Matsumura W; Fujita Y; Nakayama C; Shinkuma S; Suzuki S; Nomura T; Abe R; Shimizu H
J Dermatol Sci; 2018 Mar; 89(3):263-271. PubMed ID: 29229433
[TBL] [Abstract][Full Text] [Related]
10. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
11. Generation of a non-transmissive Borna disease virus vector lacking both matrix and glycoprotein genes.
Fujino K; Yamamoto Y; Daito T; Makino A; Honda T; Tomonaga K
Microbiol Immunol; 2017 Sep; 61(9):380-386. PubMed ID: 28776750
[TBL] [Abstract][Full Text] [Related]
12. Derivation, Expansion, and Motor Neuron Differentiation of Human-Induced Pluripotent Stem Cells with Non-Integrating Episomal Vectors and a Defined Xenogeneic-free Culture System.
Hu W; He Y; Xiong Y; Lu H; Chen H; Hou L; Qiu Z; Fang Y; Zhang S
Mol Neurobiol; 2016 Apr; 53(3):1589-1600. PubMed ID: 25663198
[TBL] [Abstract][Full Text] [Related]
13. A novel intranuclear RNA vector system for long-term stem cell modification.
Ikeda Y; Makino A; Matchett WE; Holditch SJ; Lu B; Dietz AB; Tomonaga K
Gene Ther; 2016 Mar; 23(3):256-62. PubMed ID: 26632671
[TBL] [Abstract][Full Text] [Related]
14. Production of high-titer transmission-defective RNA virus-based episomal vector using tangential flow filtration.
Komatsu Y; Kakuya Y; Tomonaga K
Microbiol Immunol; 2020 Sep; 64(9):602-609. PubMed ID: 32644225
[TBL] [Abstract][Full Text] [Related]
15. Establishing an induced pluripotent stem cell line from neonatal common marmoset fibroblasts by an all-in-one episomal vector approach.
Yoshimatsu S; Qian E; Sato T; Yamamoto M; Ishikawa M; Okano H
Stem Cell Res; 2021 May; 53():102380. PubMed ID: 34088009
[TBL] [Abstract][Full Text] [Related]
16. Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods.
Okur FV; Cevher İ; Özdemir C; Kocaefe Ç; Çetinkaya DU
Stem Cell Res Ther; 2019 Jul; 10(1):211. PubMed ID: 31315669
[TBL] [Abstract][Full Text] [Related]
17. An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells.
Haridhasapavalan KK; Borgohain MP; Dey C; Saha B; Narayan G; Kumar S; Thummer RP
Gene; 2019 Feb; 686():146-159. PubMed ID: 30472380
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
19. Generation of induced pluripotent stem cells using elastin like polypeptides as a non-viral gene delivery system.
Lee CH; Ingrole RSJ; Gill HS
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165405. PubMed ID: 30753882
[TBL] [Abstract][Full Text] [Related]
20. Simple and effective generation of transgene-free induced pluripotent stem cells using an auto-erasable Sendai virus vector responding to microRNA-302.
Nishimura K; Ohtaka M; Takada H; Kurisaki A; Tran NVK; Tran YTH; Hisatake K; Sano M; Nakanishi M
Stem Cell Res; 2017 Aug; 23():13-19. PubMed ID: 28666145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
